Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...

Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...

Alkem Laboratories launches generic empagliflozin in India as Empanorm, offering affordable treatment for diabetes and ...

The latest verdict – in a federal appeals court – has upheld the validity of a key patent on sitagliptin, the active ingredient in Januvia, as well as metformin combinations Janumet and ...

Sitagliptin, metformin (as HCl) ext-rel; 50mg/500mg, 50mg/1000mg, 100mg/1000mg; tabs. Individualize. Swallow whole. Take once daily with a meal, preferably in the evening. Not currently treated ...

493,563 with sitagliptin, and 832,295 with glipizide. Of the 43,620 new users of semaglutide in Optum's de-identified Clinformatics Data Mart Database, 56% were ages 50 to 69, 61% were women ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarterit ...

Find all the commercial and brand names of generic drug called Sitagliptin. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Kolkata: The prices of 53 medicines, including a large number of formulations used to treat diabetes, have been revised ...

Expert Rev Endocrinol Metab. 2008;3(6):691-697. Elimination of sitagliptin occurs primarily via renal excretion (79%) and involves active tubular secretion. Sitagliptin is a substrate for human ...